Abstract
The synthesis, GSK-3β inhibitory activity, and anti-microbial activity of bicyclic and tricyclic derivatives of the 5,7-diamino-6-fluoro-4-quinolone-3-carboxylic acid scaffold were studied. Kinase selectivity profiling indicated that members of this class were potent and highly selective GSK-3 inhibitors.
Copyright © 2011 Elsevier Ltd. All rights reserved.
MeSH terms
-
4-Quinolones / chemistry
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / pharmacology
-
Clinical Trials as Topic
-
Drug Design
-
Drug Evaluation, Preclinical
-
Glycogen Synthase Kinase 3 / antagonists & inhibitors*
-
Glycogen Synthase Kinase 3 / metabolism
-
Glycogen Synthase Kinase 3 beta
-
HL-60 Cells
-
High-Throughput Screening Assays
-
Humans
-
Inhibitory Concentration 50
-
Isoenzymes
-
Molecular Targeted Therapy
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Structure-Activity Relationship
-
Substrate Specificity
Substances
-
4-Quinolones
-
Anti-Bacterial Agents
-
Isoenzymes
-
Protein Kinase Inhibitors
-
GSK3B protein, human
-
Glycogen Synthase Kinase 3 beta
-
Glycogen Synthase Kinase 3